Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication.

Takuya Yamamoto1, Shinya Omoto, Masaaki Mizuguchi

  • 1Division of Nutritional Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 467-8603, Japan.

Microbiology and Immunology
|January 9, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same author

IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner.

NPJ vaccines·2026
Same author

Two autopsy cases of superficial siderosis: ultrastructural similarity across traumatic and non-traumatic contexts and forensic uncertainties.

Legal medicine (Tokyo, Japan)·2026
Same author

Editorial: Innovative vaccine strategies for enhanced flavivirus immunization.

Frontiers in cellular and infection microbiology·2025
Same author

Inducible effects of evodiamine on the uptake of glutamine in Caco-2 cells.

Journal of ethnopharmacology·2025
Same author

Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study.

Frontiers in immunology·2025

Synthetic dsRNAs targeting HIV-1 nef genes can inhibit viral transcription. Shorter dsRNAs (around 500 nucleotides) showed greater potency in suppressing viral gene expression.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Silencing

Background:

  • RNA interference (RNAi) mediates post-transcriptional gene silencing (PTGS) using double-stranded RNA (dsRNA).
  • HIV-1 infection persists in T cells and macrophages, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of synthetic dsRNAs targeting the HIV-1 nef gene to inhibit viral transcription.
  • To evaluate the efficacy of different lengths of nef dsRNA in suppressing HIV-1 gene expression.

Main Methods:

  • Cotransfection of HIV-1-infected T cell and macrophage lines with plasmids expressing target genes and synthetic nef dsRNAs.
  • Assessment of viral transcription inhibition using a luciferase reporter assay linked to the HIV-1 (SF2) LTR.

Related Experiment Videos

Main Results:

  • Synthetic dsRNAs targeting the HIV-1 nef gene demonstrated inhibition of viral transcription.
  • A defective nef dsRNA (556 nt) suppressed luciferase activity more effectively than a full-length dsRNA (744 nt).
  • Results suggest that approximately 500 nt-long dsRNA is sufficient for effective interference with HIV-1 transcription.

Conclusions:

  • Synthetic dsRNAs targeting the HIV-1 nef gene can effectively inhibit viral transcription.
  • dsRNA length is a critical factor, with shorter constructs (around 500 nt) showing enhanced potency.
  • This approach holds potential for developing novel RNA interference-based therapies against HIV-1.